ABBOTT Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABBOTT, and what generic and branded alternatives to ABBOTT drugs are available?
ABBOTT has one hundred and eleven approved drugs.
Drugs and US Patents for ABBOTT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott | DOPAMINE HYDROCHLORIDE | dopamine hydrochloride | INJECTABLE;INJECTION | 070656-001 | Jan 24, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Abbott | PANWARFIN | warfarin sodium | TABLET;ORAL | 017020-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Abbott | AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER | amino acids; dextrose | INJECTABLE;INJECTION | 019505-002 | Nov 7, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Abbott | EUTONYL | pargyline hydrochloride | TABLET;ORAL | 013448-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Abbott | CALCIUM GLUCEPTATE | calcium gluceptate | INJECTABLE;INJECTION | 083159-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ABBOTT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbott | HYTRIN | terazosin hydrochloride | CAPSULE;ORAL | 020347-002 | Dec 14, 1994 | 5,212,176 | ⤷ Sign Up |
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-003 | Aug 7, 1987 | 5,294,615 | ⤷ Sign Up |
Abbott | NORVIR | ritonavir | CAPSULE;ORAL | 020680-001 | Mar 1, 1996 | 5,635,523*PED | ⤷ Sign Up |
Abbott | MERIDIA | sibutramine hydrochloride | CAPSULE;ORAL | 020632-002 | Nov 22, 1997 | 4,746,680*PED | ⤷ Sign Up |
Abbott | MERIDIA | sibutramine hydrochloride | CAPSULE;ORAL | 020632-002 | Nov 22, 1997 | 5,436,272*PED | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ABBOTT drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Capsules | 10 mg and 15 mg | ➤ Subscribe | 2009-08-14 |
➤ Subscribe | Capsules | 100 mg | ➤ Subscribe | 2012-10-31 |
➤ Subscribe | Tablets | 100 mg | ➤ Subscribe | 2010-12-21 |
Similar Applicant Names
Here is a list of applicants with similar names.